Related Experiment Video
Updated: May 15, 2026
04:20
A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma
Published on: July 28, 2020
Local and systemic hemostatics as an adjunct to control bleeding in trauma
Chrysanthos Georgiou1, Kyriakos Neofytou, Demetrios Demetriades
1Department of Surgery, Nicosia General Hospital, Nicosia, Cyprus. chr.georgiou@traumangh.com
The American Surgeon
|January 23, 2013
Summary
Adjunct hemostatic agents offer valuable support in managing severe trauma bleeding alongside traditional surgical and angiointervention methods. This review examines the effectiveness of various hemostatic agents currently available for clinical use.
Area of Science:
- Trauma care
- Surgical hemostasis
- Pharmacological interventions
Background:
- Severe bleeding is a major cause of mortality in trauma patients.
- Surgical and angiointervention techniques are primary treatments for trauma-induced hemorrhage.
- Adjunctive therapies are increasingly explored to improve hemostasis.
Purpose of the Study:
- To review the role of hemostatic agents in severe trauma bleeding.
- To evaluate the efficacy of available local and systemic hemostatic agents.
Main Methods:
- Literature review of studies on hemostatic agents in trauma.
- Analysis of clinical data on the use of hemostatic agents.
- Synthesis of evidence regarding hemostatic agent effectiveness.
Main Results:
- Hemostatic agents can supplement surgical and angiointervention in severe bleeding.
- Various agents demonstrate potential benefits in controlling hemorrhage.
- Efficacy varies depending on the agent and clinical context.
Conclusions:
- Hemostatic agents represent an important adjunct in managing severe trauma bleeding.
- Further research is needed to optimize the use of these agents.
- Integration of hemostatic agents can improve patient outcomes in trauma care.
Related Concept Videos
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:16Vascular Spasm
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:25Acute Inflammation III: Local and Systemic Effects
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...